Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Human catalase gene promoter haplotype and cardiometabolic improvement after bariatric surgery.

Alili R, Nivet-Antoine V, Saldmann A, Golmard JL, Cottart CH, Laguillier C, Giral P, Beaudeux JL, Bouillot JL, Poitou C, Clément K, Hébert-Schuster M.

Gene. 2018 May 20;656:17-21. doi: 10.1016/j.gene.2018.02.064. Epub 2018 Feb 27.

PMID:
29496557
2.

Inhibitors of BCR signalling interrupt the survival signal mediated by the micro-environment in mantle cell lymphoma.

Bernard S, Danglade D, Gardano L, Laguillier C, Lazarian G, Roger C, Thieblemont C, Marzec J, Gribben J, Cymbalista F, Varin-Blank N, Ledoux D, Baran-Marszak F.

Int J Cancer. 2015 Jun 15;136(12):2761-74. doi: 10.1002/ijc.29326. Epub 2014 Dec 3.

3.

RANTES/CCL5 mediated-biological effects depend on the syndecan-4/PKCα signaling pathway.

Maillard L, Saito N, Hlawaty H, Friand V, Suffee N, Chmilewsky F, Haddad O, Laguillier C, Guyot E, Ueyama T, Oudar O, Sutton A, Charnaux N.

Biol Open. 2014 Sep 26;3(10):995-1004. doi: 10.1242/bio.20148227.

4.

Serum proteoglycans as prognostic biomarkers of hepatocellular carcinoma in patients with alcoholic cirrhosis.

Nault JC, Guyot E, Laguillier C, Chevret S, Ganne-Carrie N, N'Kontchou G, Beaugrand M, Seror O, Trinchet JC, Coelho J, Lasalle P, Charnaux N, Delehedde M, Sutton A, Nahon P.

Cancer Epidemiol Biomarkers Prev. 2013 Aug;22(8):1343-52. doi: 10.1158/1055-9965.EPI-13-0179. Epub 2013 Jun 18.

5.

PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis.

Guyot E, Sutton A, Rufat P, Laguillier C, Mansouri A, Moreau R, Ganne-Carrié N, Beaugrand M, Charnaux N, Trinchet JC, Nahon P.

J Hepatol. 2013 Feb;58(2):312-8. doi: 10.1016/j.jhep.2012.09.036. Epub 2012 Oct 13.

PMID:
23069476
6.

RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans.

Suffee N, Hlawaty H, Meddahi-Pelle A, Maillard L, Louedec L, Haddad O, Martin L, Laguillier C, Richard B, Oudar O, Letourneur D, Charnaux N, Sutton A.

Angiogenesis. 2012 Dec;15(4):727-44. doi: 10.1007/s10456-012-9285-x. Epub 2012 Jun 30.

PMID:
22752444
7.

Chemokine RANTES promoter dimorphisms and hepatocellular carcinoma occurrence in patients with alcoholic or hepatitis C virus-related cirrhosis.

Charni F, Sutton A, Rufat P, Laguillier C, Mansouri A, Moreau R, Ganne-Carrié N, Trinchet JC, Beaugrand M, Charnaux N, Nahon P.

Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1439-46. doi: 10.1158/1055-9965.EPI-11-0341. Epub 2011 May 24.

8.

Constitutive and B-cell receptor-induced activation of STAT3 are important signaling pathways targeted by bortezomib in leukemic mantle cell lymphoma.

Baran-Marszak F, Boukhiar M, Harel S, Laguillier C, Roger C, Gressin R, Martin A, Fagard R, Varin-Blank N, Ajchenbaum-Cymbalista F, Ledoux D.

Haematologica. 2010 Nov;95(11):1865-72. doi: 10.3324/haematol.2009.019745. Epub 2010 Jul 27.

9.

[Interference of hemoglobin variants on glycated hemoglobin measurement using Architect ci8200 immunoassay (Abbott Diagnostics)].

Succari M, Fonfrede M, Laguillier C, Wang J, Siguret V, Beaudeux JL.

Ann Biol Clin (Paris). 2009 Sep-Oct;67(5):557-62. doi: 10.1684/abc.2009.0364. French.

10.

Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis.

Nahon P, Sutton A, Rufat P, Ziol M, Akouche H, Laguillier C, Charnaux N, Ganne-Carrié N, Grando-Lemaire V, N'Kontchou G, Trinchet JC, Gattegno L, Pessayre D, Beaugrand M.

Hepatology. 2009 Nov;50(5):1484-93. doi: 10.1002/hep.23187.

PMID:
19731237
11.

Monocyte chemoattractant protein-1 (MCP-1)/CCL2 secreted by hepatic myofibroblasts promotes migration and invasion of human hepatoma cells.

Dagouassat M, Suffee N, Hlawaty H, Haddad O, Charni F, Laguillier C, Vassy R, Martin L, Schischmanoff PO, Gattegno L, Oudar O, Sutton A, Charnaux N.

Int J Cancer. 2010 Mar 1;126(5):1095-108. doi: 10.1002/ijc.24800.

12.

Efficient killing of SW480 colon carcinoma cells by a signal transducer and activator of transcription (STAT) 3 hairpin decoy oligodeoxynucleotide--interference with interferon-gamma-STAT1-mediated killing.

Tadlaoui Hbibi A, Laguillier C, Souissi I, Lesage D, Le Coquil S, Cao A, Metelev V, Baran-Marszak F, Fagard R.

FEBS J. 2009 May;276(9):2505-15. doi: 10.1111/j.1742-4658.2009.06975.x. Epub 2009 Mar 16.

13.

[Biology of arterial ageing and arteriosclerosis].

Cottart CH, Laguillier C, Nivet-Antoine V, Klimczak C, Sebban C, Beaudeux JL.

C R Biol. 2009 May;332(5):433-47. doi: 10.1016/j.crvi.2008.10.002. Epub 2008 Dec 30. Review. French.

PMID:
19393975
14.

Classification of myeloproliferative disorders in the JAK2 era: is there a role for red cell mass?

Cassinat B, Laguillier C, Gardin C, de Beco V, Burcheri S, Fenaux P, Chomienne C, Kiladjian JJ; PV-Nord Group.

Leukemia. 2008 Feb;22(2):452-3. Epub 2007 Aug 23. No abstract available.

PMID:
17713549
15.

Cell death in NF-kappaB-dependent tumour cell lines as a result of NF-kappaB trapping by linker-modified hairpin decoy oligonucleotide.

Laguillier C, Hbibi AT, Baran-Marszak F, Metelev V, Cao A, Cymbalista F, Bogdanov A Jr, Fagard R.

FEBS Lett. 2007 Mar 20;581(6):1143-50. Epub 2007 Feb 20.

16.

Effect of tumor necrosis factor alpha and infliximab on apoptosis of B lymphocytes infected or not with Epstein-Barr virus.

Baran-Marszak F, Laguillier C, Youlyouz I, Feuillard J, Mariette X, Fagard R, Raphaël M.

Cytokine. 2006 Mar 21;33(6):337-45. Epub 2006 May 19.

PMID:
16713282
17.

Latent membrane protein 1 regulates STAT1 through NF-kappaB-dependent interferon secretion in Epstein-Barr virus-immortalized B cells.

Najjar I, Baran-Marszak F, Le Clorennec C, Laguillier C, Schischmanoff O, Youlyouz-Marfak I, Schlee M, Bornkamm GW, Raphaël M, Feuillard J, Fagard R.

J Virol. 2005 Apr;79(8):4936-43.

Supplemental Content

Loading ...
Support Center